We are live on ! Find out more
ACPU

Arrowgrass Capital Partners (US) Portfolio holdings

AUM $380M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+20.87%
3 Year Est. Return
+55.83%
5 Year Est. Return
+146.17%
10 Year Est. Return
AUM
$9.74B
AUM Growth
+$896M
Cap. Flow
-$1.5B
Cap. Flow %
-15.38%
Top 10 Hldgs %
18.97%
Holding
669
New
134
Increased
215
Reduced
130
Closed
98

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$212M
2
STJ
St Jude Medical
STJ
+$189M
3
RAD
Rite Aid Corporation
RAD
+$131M
4
GE icon
GE Aerospace
GE
+$121M
5
FTI icon
TechnipFMC
FTI
+$94.2M

Sector Composition

Rank Sector Weight
1 Technology 8.63%
2 Communication Services 6.61%
3 Consumer Staples 4.09%
4 Financials 3.7%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
326
Merck
MRK
$322B
$4.57M 0.05%
75,345
-196,983
-72% -$12M
GOOGL icon
327
CALL
Alphabet (Google) Class A
GOOGL
$4.36T
$4.49M 0.05%
1,060
SPLS
328
PUT
DELISTED
Staples Inc
SPLS
$4.38M 0.05%
+5,000
New +$45.1K
WY icon
329
PUT
Weyerhaeuser
WY
$18B
$4.36M 0.04%
+1,283
New +$41.7K
COST icon
330
Costco
COST
$422B
$4.33M 0.04%
25,853
+1,980
+8% +$332K
TMO icon
331
PUT
Thermo Fisher Scientific
TMO
$213B
$4.32M 0.04%
281
+143
+104% +$21.9K
CAT icon
332
Caterpillar
CAT
$375B
$4.28M 0.04%
46,186
-24,319
-34% -$2.3M
MDT icon
333
PUT
Medtronic
MDT
$109B
$4.27M 0.04%
530
+315
+147% +$24.6K
HCA icon
334
HCA Healthcare
HCA
$87.2B
$4.26M 0.04%
47,891
+3,666
+8% +$306K
JNJ icon
335
CALL
Johnson & Johnson
JNJ
$618B
$4.2M 0.04%
337
-1,024
-75% -$122K
UNH icon
336
CALL
UnitedHealth
UNH
$376B
$4.15M 0.04%
253
BIIB icon
337
CALL
Biogen
BIIB
$30B
$4.1M 0.04%
150
-480
-76% -$136K
PX
338
DELISTED
Praxair Inc
PX
$4.06M 0.04%
+34,238
New +$4.03M
MNST icon
339
PUT
Monster Beverage
MNST
$94.3B
$4M 0.04%
1,734
RTX icon
340
PUT
RTX Corp
RTX
$290B
$3.96M 0.04%
561
-523
-48% -$36.7K
JNS
341
DELISTED
Janus Capital Group Inc
JNS
$3.96M 0.04%
+300,000
New +$3.83M
SNAP icon
342
Snap
SNAP
$7.89B
$3.94M 0.04%
+175,000
New +$3.88M
AGN
343
CALL
DELISTED
Allergan plc
AGN
$3.94M 0.04%
165
-666
-80% -$155K
CCL icon
344
Carnival Corporation Ltd
CCL
$38.1B
$3.94M 0.04%
66,898
-10,583
-14% -$592K
F icon
345
Ford
F
$58.5B
$3.87M 0.04%
332,029
+288,144
+657% +$3.58M
JNJ icon
346
Johnson & Johnson
JNJ
$618B
$3.81M 0.04%
30,605
+16,685
+120% +$1.99M
TFC icon
347
Truist Financial
TFC
$63.3B
$3.79M 0.04%
84,749
+4,247
+5% +$198K
DVN icon
348
PUT
Devon Energy
DVN
$52.1B
$3.75M 0.04%
900
AVGO icon
349
Broadcom
AVGO
$1.85T
$3.74M 0.04%
170,720
-49,610
-23% -$1.02M
BMY icon
350
Bristol-Myers Squibb
BMY
$133B
$3.71M 0.04%
+68,289
New +$3.75M

Similar funds

Arrowgrass Capital Partners (US)'s Q1 2017 Portfolio in Review

As of Q1 2017, Arrowgrass Capital Partners (US) held 669 positions worth $9.74B, up 10% from $8.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Arrowgrass Capital Partners (US) withdrew a net $1.5B in Q1 2017, closing 98 positions and reducing 130 holdings. Its most notable exit was Humana, an estimated $212M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 8.3% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Arrowgrass Capital Partners (US) opened a new position in Time Warner Inc worth $229M.

  • Arrowgrass Capital Partners (US)'s largest Q1 2017 buy was Time Warner Inc: 2,343,696 shares worth $229M.
  • Arrowgrass Capital Partners (US) added most to Mastercard in Q1 2017, an estimated $34.5M increase.
  • Arrowgrass Capital Partners (US)'s biggest Q1 2017 reduction was GE Aerospace, cutting an estimated $121M.
  • Arrowgrass Capital Partners (US) fully exited Humana in Q1 2017, selling an estimated $212M.
  • Arrowgrass Capital Partners (US)'s ten largest holdings make up 19% of its $9.74B portfolio in Q1 2017.
  • Arrowgrass Capital Partners (US) opened 134 new positions and closed 98 in Q1 2017.
  • Arrowgrass Capital Partners (US)'s portfolio value rose 10% quarter-over-quarter to $9.74B.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2017, filed 15 May 2017.